Treatment with biologic DMARDs vs standard therapy improved clinical response rates and flare outcomes among patients with polyarticular JIA.
SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...
MedPage Today on MSN
Not all drugs approved for rheumatoid arthritis are equal for pain relief
Among rheumatoid arthritis (RA) patients responding to upadacitinib (Rinvoq) or adalimumab, those receiving the former had ...
SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today ...
Al-Gahtani, S. (2026) Review of Literature Investigating the Correlation between Prevalence of Risk Factors Associated with ...
Minimal disease activity (MDA) was more likely in people with psoriatic arthritis (PsA) when they initiated a disease-modifying anti-rheumatic drug (DMARD) earlier rather than later. That's according ...
Our objective was to describe characteristics and compare clinical and patient-reported outcomes (PROs) for disease-modifying antirheumatic drug (DMARD)-naive patients with psoriatic arthritis (PsA) ...
For decades, the only medical treatments for rheumatoid arthritis (RA) and other autoimmune diseases have been medications. These drugs work by turning off parts of the immune system that cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback